Capital Corner
By Will Melofchik – NCOIL General Counsel
Greetings – Welcome to the latest installment of Capital Corner, a column that aims to update you on some of the issues that NCOIL is following. Below are some of the issues that NCOIL will be discussing at the upcoming NCOIL Spring Meeting and will be monitoring throughout 2024.
Nashville General Sessions Are Can’t-Miss Events
At the upcoming Spring Meeting in Nashville, two general sessions will be held which will feature two of the most talked about issues in the nation. On Friday, April 12, a session will be held focusing on the latest trends in the development of and coverage for anti-obesity drugs.
During the 2021 Summer Meeting in Boston, a similar session was held but it coincided almost in lockstep with the introduction in availability of what are now ubiquitous weight loss drugs. Indeed, Wegovy was approved by the U.S. Food and Drug Administration (FDA) for use just weeks before the Summer Meeting1. Accordingly, in light of the surge in popularity and numerous public policy questions that have arisen the past few years surrounding weight loss drugs, this session will be a great opportunity to hear from a panel of experts as to what the latest issues currently are and will be going forward when it comes to using these drugs to tackle the obesity crisis while ensuring that healthcare payers’, including insurance carriers, return on investment is realized.
Download to read more